Infliximab therapy for complicated sarcoidosis

Ann Intern Med. 2002 Aug 20;137(4):296-7; author reply 296-7. doi: 10.7326/0003-4819-137-4-200208200-00022.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Infliximab
  • Recurrence
  • Sarcoidosis / drug therapy*
  • Tuberculosis, Pulmonary / etiology*
  • Tumor Necrosis Factor-alpha / drug effects*

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab